MS sufferer slams MHK's cannabis comments
Warning message
The subscription service is currently unavailable. Please try again later.MS sufferer hits out
A Ramsey MHK's comments about cannabis and prescriptions have been labelled 'atrocious' by an MS sufferer.
This week, Leonard Singer said he was opposed to the drug being permitted for medicinal use because people who obtained it on prescription could just give it to other people. He does however, support the use of cannabis-derived, approved prescription drugs such as Sativex.
Di, who has MS uses Sativex spray to help alleviate some of the elements of her condition.
She rejects the argument that prescriptions could be sold or passed on, as a reason to oppose allowing the medicinal use of cannabis.
This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.
420 Intel is Your Source for Marijuana News
420 Intel Canada is your leading news source for the Canadian cannabis industry. Get the latest updates on Canadian cannabis stocks and developments on how Canada continues to be a major player in the worldwide recreational and medical cannabis industry.
420 Intel Canada is the Canadian Industry news outlet that will keep you updated on how these Canadian developments in recreational and medical marijuana will impact the country and the world. Our commitment is to bring you the most important cannabis news stories from across Canada every day of the week.
Marijuana industry news is a constant endeavor with new developments each day. For marijuana news across the True North, 420 Intel Canada promises to bring you quality, Canadian, cannabis industry news.
You can get 420 Intel news delivered directly to your inbox by signing up for our daily marijuana news, ensuring you’re always kept up to date on the ever-changing cannabis industry. To stay even better informed about marijuana legalization news follow us on Twitter, Facebook and LinkedIn.
Â
Follow us on Instagram
Connect with us on Linkedin